Lexicon Pharmaceuticals Inc

NASDAQ:LXRX   4:00:00 PM EDT
2.11
-0.05 (-2.32%)
4:28:05 PM EDT: $2.09 -0.02 (-0.95%)
Earnings Announcements

Lexicon Pharmaceuticals Reports Third Quarter 2022 Financial Results

Published: 11/09/2022 21:11 GMT
Lexicon Pharmaceuticals Inc (LXRX) - Lexicon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update.
Lexicon Pharmaceuticals Inc - Net Loss for Q3 of 2022 Was $23.4 Million, Or $0.13 per Share.
Revenue is expected to be $0.05 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.14

More details on our Analysts Page.